Gamma reactivation using the spongy effect of KLF1-binding site sequence: an approach in gene therapy for beta-thalassemia.

about

Gamma reactivation using the spongy effect of KLF1-binding site sequence: an approach in gene therapy for beta-thalassemia.

Item

http://www.wikidata.org/entity/Q38729714

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Gamma reactivation using the s ...... therapy for beta-thalassemia.

@en

type

Item

label

Gamma reactivation using the s ...... therapy for beta-thalassemia.

@en

prefLabel

Gamma reactivation using the s ...... therapy for beta-thalassemia.

@en

P1476

Gamma reactivation using the s ...... therapy for beta-thalassemia.

@en

P2093

Hossein Khanahmad

http://www.w3.org/2001/XMLSchema#string

Laleh Shariati

http://www.w3.org/2001/XMLSchema#string

Mansoor Salehi

http://www.w3.org/2001/XMLSchema#string

Mansoureh Shahbazi

http://www.w3.org/2001/XMLSchema#string

Nasrin Heydari

http://www.w3.org/2001/XMLSchema#string

Zahra Hejazi

http://www.w3.org/2001/XMLSchema#string

P2860

Haploinsufficiency for the erythroid transcription factor KLF1 causes hereditary persistence of fetal hemoglobin

Mi2β is required for γ-globin gene silencing: temporal assembly of a GATA-1-FOG-1-Mi2 repressor complex in β-YAC transgenic mice

Transcriptional silencing of {gamma}-globin by BCL11A involves long-range interactions and cooperation with SOX6.

A zinc-finger transcriptional activator designed to interact with the gamma-globin gene promoters enhances fetal hemoglobin production in primary human adult erythroblasts

Induction of adult levels of β-globin in human erythroid cells that intrinsically express embryonic or fetal globin by transduction with KLF1 and BCL11A-XL

Therapeutic levels of fetal hemoglobin in erythroid progeny of β-thalassemic CD34+ cells after lentiviral vector-mediated gene transfer.

Transcriptional regulation of fetal to adult hemoglobin switching: new therapeutic opportunities.

Induction of human fetal hemoglobin via the NRF2 antioxidant response signaling pathway

A functional element necessary for fetal hemoglobin silencing

Erythroid Kruppel-like factor (EKLF) is recruited to the gamma-globin gene promoter as a co-activator and is required for gamma-globin gene induction by short-chain fatty acid derivatives

P304

1063-1069

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27872702

http://www.w3.org/2001/XMLSchema#string

P921

gene therapy

P932

5110654

http://www.w3.org/2001/XMLSchema#string